Abstract
ABSTRACT: In a small‐scale preliminary trial of oral rifampicin treatment was considered successful in six out of eight cutaneous leishmaniasis patients and probably effective in a seventh. The in vitro effect of rifampicin on leishmania organisms concerns inhibition of mitochondrial function or replication. The need for protozoological control in the assessment of treatment is stressed.
| Original language | English |
|---|---|
| Pages (from-to) | 110-112 |
| Number of pages | 3 |
| Journal | International Journal of Dermatology |
| Volume | 21 |
| Issue number | 2 |
| DOIs | |
| State | Published - 1 Jan 1982 |
| Externally published | Yes |
ASJC Scopus subject areas
- Dermatology